Abstract
Extracellular vesicles (EVs) transport biomolecules that mediate intercellular communication. We previously showed that EVs contain DNA (EV-DNA) representing the entire genome. However, the mechanism of genomic EV-DNA packaging and its role in cancer remain elusive. We now demonstrate that EV-DNA is predominantly localized on the vesicle surface and associated with uniquely modified and cleaved histones. Moreover, a genome-wide clustered regularly interspaced short palindromic repeats knockout screen revealed that immune developmental pathways and genes, including apoptotic peptidase activating factor 1 (APAF1) and neutrophil cytosolic factor 1 (NCF1), regulate EV-DNA packaging. Furthermore, in colorectal cancer models, uptake of EV-DNA by pre-metastatic liver Kupffer cells (KCs) activated DNA damage responses. This activation rewired KC cytokine production and promoted the formation of tertiary lymphoid structures, thereby suppressing liver metastasis. Conversely, loss of APAF1 decreased EV-DNA packaging and promoted liver metastasis. Importantly, colorectal cancer biopsy EV-DNA secretion could serve as a predictive biomarker for postoperative metastasis. Taken together, our findings indicate that uniquely chromatinized EV-DNA induces antitumor immunity.
Funding Information
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA224175 (D.L.), CA210240 (D.L.), CA232093 (D.L.), CA207983 (D.L.), CA169538 (D.L.) and CA218513)
  • Hartwell Foundation
  • Worldwide Cancer Research (23-0105)
  • Korea Health Industry Development Institute (HI19C1330)
  • Center for Strategic Scientific Initiatives, National Cancer Institute (CA218513)
  • Tortolani Foundation, Sussman family fund, Lerner Foundation
  • Pershing Square Foundation (P30 CA008748, P50 CA192937, R35 GM138386)
  • Ministry of Trade, Industry and Energy (20012443)